Sumitomo Dainippon Pharma Oncology appoints Jatin J. Shah as Chief Medical Officer
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
Zerion´s innovative Dispersome technology builds on a new concept of increasing drug solubility by using natural protein-based excipients to formulate APIs into amorphous solid dispersions (ASDs) by spray drying
Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad
It is used to control, prevent and normalize the symptoms associated with Alzheimer's disease, attention disorder, bipolar disorder, Parkinson's disease among others
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Appoints Dr Rafiq Hasan as CEO
he financing was significantly oversubscribed with high demand from both existing and new investors.
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
Subscribe To Our Newsletter & Stay Updated